CDTX
Price
$49.45
Change
+$0.12 (+0.24%)
Updated
Jun 27 closing price
Capitalization
1.04B
TNXP
Price
$34.89
Change
-$0.65 (-1.83%)
Updated
Jun 27 closing price
Capitalization
256.62M
43 days until earnings call
Interact to see
Advertisement

CDTX vs TNXP

Header iconCDTX vs TNXP Comparison
Open Charts CDTX vs TNXPBanner chart's image
Cidara Therapeutics
Price$49.45
Change+$0.12 (+0.24%)
Volume$3.75M
Capitalization1.04B
Tonix Pharmaceuticals Holding
Price$34.89
Change-$0.65 (-1.83%)
Volume$1.95M
Capitalization256.62M
CDTX vs TNXP Comparison Chart in %
Loading...
CDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CDTX vs. TNXP commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDTX is a Buy and TNXP is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (CDTX: $49.45 vs. TNXP: $34.89)
Brand notoriety: CDTX and TNXP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CDTX: 701% vs. TNXP: 200%
Market capitalization -- CDTX: $1.04B vs. TNXP: $256.62M
CDTX [@Biotechnology] is valued at $1.04B. TNXP’s [@Biotechnology] market capitalization is $256.62M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CDTX’s FA Score shows that 0 FA rating(s) are green whileTNXP’s FA Score has 2 green FA rating(s).

  • CDTX’s FA Score: 0 green, 5 red.
  • TNXP’s FA Score: 2 green, 3 red.
According to our system of comparison, TNXP is a better buy in the long-term than CDTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CDTX’s TA Score shows that 4 TA indicator(s) are bullish while TNXP’s TA Score has 4 bullish TA indicator(s).

  • CDTX’s TA Score: 4 bullish, 4 bearish.
  • TNXP’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, TNXP is a better buy in the short-term than CDTX.

Price Growth

CDTX (@Biotechnology) experienced а +135.25% price change this week, while TNXP (@Biotechnology) price change was +1.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

TNXP is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CDTX($1.04B) has a higher market cap than TNXP($257M). CDTX YTD gains are higher at: 83.966 vs. TNXP (5.791). TNXP has higher annual earnings (EBITDA): -66.23M vs. CDTX (-192.6M). CDTX has more cash in the bank: 168M vs. TNXP (132M). TNXP has less debt than CDTX: TNXP (563K) vs CDTX (2.67M). TNXP has higher revenues than CDTX: TNXP (10M) vs CDTX (302K).
CDTXTNXPCDTX / TNXP
Capitalization1.04B257M403%
EBITDA-192.6M-66.23M291%
Gain YTD83.9665.7911,450%
P/E RatioN/A0.10-
Revenue302K10M3%
Total Cash168M132M127%
Total Debt2.67M563K475%
FUNDAMENTALS RATINGS
CDTX vs TNXP: Fundamental Ratings
CDTX
TNXP
OUTLOOK RATING
1..100
9855
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
26
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
3447
P/E GROWTH RATING
1..100
10016
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TNXP's Valuation (26) in the Pharmaceuticals Other industry is somewhat better than the same rating for CDTX (86) in the Biotechnology industry. This means that TNXP’s stock grew somewhat faster than CDTX’s over the last 12 months.

TNXP's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as CDTX (100) in the Biotechnology industry. This means that TNXP’s stock grew similarly to CDTX’s over the last 12 months.

TNXP's SMR Rating (98) in the Pharmaceuticals Other industry is in the same range as CDTX (100) in the Biotechnology industry. This means that TNXP’s stock grew similarly to CDTX’s over the last 12 months.

CDTX's Price Growth Rating (34) in the Biotechnology industry is in the same range as TNXP (47) in the Pharmaceuticals Other industry. This means that CDTX’s stock grew similarly to TNXP’s over the last 12 months.

TNXP's P/E Growth Rating (16) in the Pharmaceuticals Other industry is significantly better than the same rating for CDTX (100) in the Biotechnology industry. This means that TNXP’s stock grew significantly faster than CDTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CDTXTNXP
RSI
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
85%
Momentum
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
74%
MACD
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 20 days ago
85%
N/A
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
79%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
CDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HPQFF0.12N/A
+0.25%
HPQ SILICON INC
GPTGF2.98N/A
N/A
GPT Group
BGLAF9.58N/A
N/A
Biogaia AB
CRBJF3.60-0.33
-8.40%
China Resources Land Ltd.
ASWRF0.02N/A
-11.89%
Gungnir Resources Inc.

CDTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDTX has been closely correlated with WINT. These tickers have moved in lockstep 94% of the time. This A.I.-generated data suggests there is a high statistical probability that if CDTX jumps, then WINT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDTX
1D Price
Change %
CDTX100%
+0.24%
WINT - CDTX
94%
Closely correlated
+21.49%
NBY - CDTX
93%
Closely correlated
+0.97%
NCNA - CDTX
93%
Closely correlated
N/A
SNPX - CDTX
93%
Closely correlated
+23.37%
BPTSY - CDTX
92%
Closely correlated
N/A
More

TNXP and

Correlation & Price change

A.I.dvisor indicates that over the last year, TNXP has been closely correlated with NCNA. These tickers have moved in lockstep 90% of the time. This A.I.-generated data suggests there is a high statistical probability that if TNXP jumps, then NCNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNXP
1D Price
Change %
TNXP100%
-1.83%
NCNA - TNXP
90%
Closely correlated
N/A
SNPX - TNXP
88%
Closely correlated
+23.37%
WINT - TNXP
88%
Closely correlated
+21.49%
RNAC - TNXP
88%
Closely correlated
-6.81%
CDTX - TNXP
87%
Closely correlated
+0.24%
More